TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34615722

Group type: EXPERIMENTAL
Intervention: Anthracycline adjuvant chemotherapy in basal breast cancer patients
Number of subjects: 819

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen in basal breast cancer patients
Number of subjects: 819
Study: 33341833

Group type: EXPERIMENTAL
Intervention: Instrumental ney music played in the modal rhythm of Segah (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No intervention (Group B)
Number of subjects: 30
Study: 36215044

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) with medical therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Medical therapy alone (Control)
Number of subjects: 202
Study: 34280784

Group type: EXPERIMENTAL
Intervention: Subarachnoid anaesthesia (SA)
Number of subjects: 138

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 138
Study: 33882531

Group type: EXPERIMENTAL
Intervention: Integrated mental health and acute care clinical model on a dedicated education unit (DEU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional experience on an acute care and inpatient behavioral health unit
Number of subjects: 0
Study: 32998098

Group type: EXPERIMENTAL
Intervention: Salt stress treatment (low, medium, high)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gene ontology analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KEGG pathway annotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: qRT-PCR analysis
Number of subjects: 0
Study: 32359068

Group type: EXPERIMENTAL
Intervention: Implementation intention group (IMP)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Enhanced implementation intention group (IMP+)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control goal intention group (GOL)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: All groups (IMP, IMP+, GOL)
Number of subjects: 95
Study: 33126334

Group type: EXPERIMENTAL
Intervention: Motion Style Acupuncture Treatment (MSAT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Acupuncture Treatment
Number of subjects: 128
Study: 36120765

Group type: EXPERIMENTAL
Intervention: Physiotherapy instrument mobilization (PIM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Manual mobilization
Number of subjects: 32
Study: 34425156

Group type: COMPARATOR
Intervention: Low initial oxygen concentration (≤30%)
Number of subjects: 720

Group type: COMPARATOR
Intervention: High initial oxygen concentration (≥60%)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Prolonged bradycardia (HR <100 bpm for ≥2 min)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Prolonged bradycardia and SpO2 <80% at 5 min after birth
Number of subjects: 720
Study: 34289338

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab 0.5 or 2.0 mg (all treatment arms pooled)
Number of subjects: 917
Study: 34335043

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy combined with static magnetic field (PBMT-sMF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35266003

Group type: EXPERIMENTAL
Intervention: Haemodynamic-guided management (treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 33625027

Group type: EXPERIMENTAL
Intervention: Pecs blocks (n = 16)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (n = 20)
Number of subjects: 36
Study: 34915762

Group type: EXPERIMENTAL
Intervention: Psilocybin microdosing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35392354

Group type: EXPERIMENTAL
Intervention: Intravenous Ketamine (0.5 mg/kg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intrathecal Meperidine (0.2 mg/kg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intravenous Normal Saline (placebo)
Number of subjects: 150
Study: 32664375

Group type: EXPERIMENTAL
Intervention: Strength program
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Aqua fitness program
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Aerobic program
Number of subjects: 316
Study: 35364722

Group type: EXPERIMENTAL
Intervention: 1540nm non-ablative fractional laser (NAFL) combined with silicones treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: Silicones alone treatment
Number of subjects: 70
Study: 34108518

Group type: EXPERIMENTAL
Intervention: FOLFIRI/bevacizumab
Number of subjects: 486
Study: 36176051

Group type: COMPARATOR
Intervention: Vutiglabridin (30-720 mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vutiglabridin (240-480 mg once daily for 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vutiglabridin (240 mg single dose) with food effect evaluation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vutiglabridin (multiple doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vutiglabridin (MAD study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vutiglabridin (general findings)
Number of subjects: 0
Study: 33210938

Group type: EXPERIMENTAL
Intervention: High-Intensity (HI; 412 h, $4,373 per participant)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Low-Intensity (LI; 24 h, $97 per participant)
Number of subjects: 218
Study: 35726493

Group type: EXPERIMENTAL
Intervention: Stroop task
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2-back task
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 90
Study: 34474622

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT) applied to paraspinal muscles
Number of subjects: 32

Group type: COMPARATOR
Intervention: Neuro‐Developmental Treatment (NDT) programs
Number of subjects: 32
Study: 35573718

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 32331056

Group type: EXPERIMENTAL
Intervention: LEM5
Number of subjects: 1693

Group type: EXPERIMENTAL
Intervention: LEM10
Number of subjects: 1693

Group type: COMPARATOR
Intervention: PBO
Number of subjects: 1693
Study: 34849659

Group type: EXPERIMENTAL
Intervention: Ischaemic postconditioning (IPost)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Standard operation (Control)
Number of subjects: 209
Study: 36072410

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with 50 mg diclofenac sodium (DS) sustained-release capsules once a day, treated three times in 7 days.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose diclofenac sodium (50 mg DS sustained-release capsules once a day).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional-dose diclofenac sodium (100 mg DS sustained-release capsules once a day).
Number of subjects: 0
Study: 32282572

Group type: EXPERIMENTAL
Intervention: Trunk stabilization training robot (3DBT‐33) in addition to conventional physical therapy (30 min)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 38
Study: 35639696

Group type: EXPERIMENTAL
Intervention: Individual drum tuition (two lessons per week over an 8‐wk period)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no drum tuition)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Individual drum tuition
Number of subjects: 36
Study: 34700609

Group type: EXPERIMENTAL
Intervention: NBTXR3 + RT
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: NBTXR3 + RT + anti-PD-1
Number of subjects: 9

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 9
Study: 36368938

Group type: EXPERIMENTAL
Intervention: Individualised medicine management plan (MMP) plus Discharge Medical Service (DMS)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Discharge Medical Service (DMS) only
Number of subjects: 682
Study: 33470681

Group type: EXPERIMENTAL
Intervention: Topical ocular hypertonic saline
Number of subjects: 16
Study: 32668487

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (non-penetrating acupuncture)
Number of subjects: 36
Study: 35804037

Group type: COMPARATOR
Intervention: Conventional motorized treadmill (MT)
Number of subjects: 9
Study: 34505215

Group type: EXPERIMENTAL
Intervention: Contact intervention involving LGBT educators' 'coming-out story'
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 117
Study: 35354614

Group type: EXPERIMENTAL
Intervention: DGAT2 inhibitor (PF‐06865571, ervogastat) 25-300 mg BID or 150-300 mg once a day
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: DGAT2 inhibitor (PF‐06865571, ervogastat) 150-300 mg BID + ACC inhibitor (PF‐05221304, clesacostat) 5-10 mg BID
Number of subjects: 450

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 450
Study: 34107792

Group type: EXPERIMENTAL
Intervention: Topical silicone gel only
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Pressure garment only
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Combined topical silicone gel and pressure garment
Number of subjects: 153
Study: 32360852

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with a diode laser (670 nm, 150 mW, 1.1 W/cm2) and methylene blue photosensitizer (0.005% concentration) applied once at baseline.
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with adjunctive mechanical debridement.
Number of subjects: 71
Study: 33893561

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 6632

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6632
Study: 33906601

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted technique
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional puncture method
Number of subjects: 144
Study: 32689839

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) + Proportional Assisted Ventilation (PAV)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Proportional Assisted Ventilation (PAV)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 9
Study: 33980046

Group type: EXPERIMENTAL
Intervention: Baseline penumbra
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Noninfarcted penumbra at 24 hours (WAKE‐UP)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Noninfarcted penumbra at 30 days (AXIS 2)
Number of subjects: 126
Study: 32363592

Group type: EXPERIMENTAL
Intervention: Varenicline (up to 2 mg/d)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 35770579

Group type: EXPERIMENTAL
Intervention: Yamamoto New Scalp Acupuncture (YNSA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no application of acupuncture)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: YNSA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 33499916

Group type: EXPERIMENTAL
Intervention: Normobaric oxygenation (NBO) - high-flow oxygen (8 L/min, 1 hour each time for 6 cycles daily) and low-flow oxygen (2 L/min) for a total of 7 days.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Low-flow oxygen (2 L/min) by mask for 7 consecutive days (Control group).
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Normobaric oxygenation (NBO)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Low-flow oxygen (2 L/min) (Control group)
Number of subjects: 150
Study: 32857616

Group type: EXPERIMENTAL
Intervention: 2,000 IU/day oral vitamin D supplementation for 4 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 μM Tempol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 μM apocynin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lactated Ringer's solution (control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: l-NAME (NO synthase inhibitor)
Number of subjects: 18
Study: 35134631

Group type: EXPERIMENTAL
Intervention: Oral treprostinil (taken three times daily)
Number of subjects: 690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study: 34744686

Group type: EXPERIMENTAL
Intervention: Standardized physical activity intervention (twice a week for 45 min, lasting 16 weeks)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Standardized physical activity intervention
Number of subjects: 49
Study: 32889793

Group type: EXPERIMENTAL
Intervention: Oral health knowledge assessment
Number of subjects: 3091

Group type: EXPERIMENTAL
Intervention: Oral health attitude assessment
Number of subjects: 3091

Group type: EXPERIMENTAL
Intervention: Knowledge about dental hygiene practices
Number of subjects: 3091

Group type: EXPERIMENTAL
Intervention: Knowledge about diet and oral hygiene
Number of subjects: 3091

Group type: EXPERIMENTAL
Intervention: Oral health behaviors and practices
Number of subjects: 3091
Study: 32443379

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain aspirin
Number of subjects: 0
Study: 34979429

Group type: EXPERIMENTAL
Intervention: Ankle plantar flexor force-matching exercises at 5% MVC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ankle plantar flexor force-matching exercises at 20% MVC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ankle plantar flexor force-matching exercises at 50% MVC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ankle plantar flexor force-matching exercises (all target torques)
Number of subjects: 28
Study: 33289803

Group type: EXPERIMENTAL
Intervention: Self‐ligating brackets (SB)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional brackets (CB)
Number of subjects: 134
Study: 32706400

Group type: EXPERIMENTAL
Intervention: L‐shaped miniplate osteosynthesis (P2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional single miniplate osteosynthesis (P1)
Number of subjects: 40
Study: 616636097

Group type: EXPERIMENTAL
Intervention: Internet-based exposure treatment
Number of subjects: 105
Study: 35312562

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 34214918

Group type: EXPERIMENTAL
Intervention: Testosterone (in Study 1 and Study 2)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo (in Study 1 and Study 2)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Endogenous testosterone (in Study 3)
Number of subjects: 356
Study: 35294738

Group type: EXPERIMENTAL
Intervention: Curcuwin Ultra+ (CU+) 250 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Curcuwin Ultra+ (CU+) 500 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: TUR1800 1900 mg
Number of subjects: 24
Study: 32927752

Group type: EXPERIMENTAL
Intervention: Cooking for Vitality (C4V) intervention
Number of subjects: 0
Study: 35222592

Group type: EXPERIMENTAL
Intervention: Ice pack
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gel pad
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no cold application)
Number of subjects: 180
Study: 32532283

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) associated with conventional cardiac rehabilitation (CR) protocol 7 days a week for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation (CR) protocol
Number of subjects: 0
Study: 34794330

Group type: EXPERIMENTAL
Intervention: Calorie-restricted diet enriched with 39-60 g/d of mixed nuts (CRDEN) for 8 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Calorie-restricted diet without nuts (CRD) for 8 weeks
Number of subjects: 67
Study: 33480468

Group type: EXPERIMENTAL
Intervention: Ongoing sex with a regular sexual partner (RSP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: History of BV
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sex with an RSP
Number of subjects: 75
Study: 34959823

Group type: EXPERIMENTAL
Intervention: Inositol-stabilized arginine silicate (ASI) (1.5 g ASI + 12 g dextrose)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (12 g dextrose)
Number of subjects: 19
Study: 35338064

Group type: EXPERIMENTAL
Intervention: Functional Partial Body Weight Support Treadmill Training (FPBWSTT) for 4 weeks, 5 days/week, 45 min/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33234843

Group type: EXPERIMENTAL
Intervention: Telephone-based application of the ABILOCO questionnaire
Number of subjects: 92

Group type: COMPARATOR
Intervention: Face-to-face application of the ABILOCO questionnaire
Number of subjects: 92
Study: 36057768

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33631385

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 34854695

Group type: EXPERIMENTAL
Intervention: Information session, activity tracker, regular motivational emails
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control wait‐list group
Number of subjects: 126
Study: 33969121

Group type: EXPERIMENTAL
Intervention: Conventional bracket
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Self‐ligating bracket
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ceramic bracket
Number of subjects: 18
Study: 32223104

Group type: EXPERIMENTAL
Intervention: SNMS+ECSW
Number of subjects: 65

Group type: COMPARATOR
Intervention: Biofeedback combined with electrical stimulation (Control)
Number of subjects: 65
Study: 34339954

Group type: EXPERIMENTAL
Intervention: Low monoenergetic DECT images
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional images
Number of subjects: 45
Study: 32370802

Group type: COMPARATOR
Intervention: 0.6 mg/day folic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.625 mg/day (6S)-5-methyltetrahydrofolic acid
Number of subjects: 60
Study: 35831241

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma therapy (3 application sessions at 15-day intervals)
Number of subjects: 20
Study: 34447873

Group type: COMPARATOR
Intervention: Video clips
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Still images
Number of subjects: 332
Study: 35636621

Group type: EXPERIMENTAL
Intervention: Decipher genomic classifier high
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Decipher genomic classifier low-intermediate
Number of subjects: 350

Group type: COMPARATOR
Intervention: Dose escalation (64 Gy vs 70 Gy)
Number of subjects: 350
Study: 33626969

Group type: EXPERIMENTAL
Intervention: JNJ‐55920839 (10 mg/kg IV doses every 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JNJ‐55920839
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32618386

Group type: EXPERIMENTAL
Intervention: Liraglutide (≤1.8 mg daily)
Number of subjects: 9338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9338
Study: 34472194

Group type: EXPERIMENTAL
Intervention: Transcodent painless needle tips
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular needle tips
Number of subjects: 30
Study: 34293255

Group type: EXPERIMENTAL
Intervention: ASV 1.1
Number of subjects: 26

Group type: COMPARATOR
Intervention: APV-CMV
Number of subjects: 26
Study: 33970700

Group type: EXPERIMENTAL
Intervention: Septoplasty with Bilateral Inferior Turbinoplasty (BIT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Septoplasty alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Septoplasty with BIT
Number of subjects: 80
Study: 32668834

Group type: EXPERIMENTAL
Intervention: Tunneling without a catheter loop (TG2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tunneling with a catheter loop (TG1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tunneling techniques (TG1 and TG2)
Number of subjects: 150
Study: 32660282

Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg every-8-weeks
Number of subjects: 837

Group type: COMPARATOR
Intervention: adalimumab 40 mg every-2-weeks
Number of subjects: 837

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 837
Study: 32997575

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks
Number of subjects: 418

Group type: COMPARATOR
Intervention: Dacarbazine 1,000 mg/m2 every 3 weeks
Number of subjects: 418
Study: 32406770

Group type: COMPARATOR
Intervention: Protocol A (100% equivalent dose with conventional protocol)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Protocol B (80% equivalent dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Protocol C (64% equivalent dose)
Number of subjects: 40
Study: 33593768

Group type: EXPERIMENTAL
Intervention: Intensive praziquantel (PZQ) treatment: three doses, each 2 weeks apart before BCG immunisation, followed by a dose at week 8 and quarterly thereafter.
Number of subjects: 480

Group type: COMPARATOR
Intervention: Standard praziquantel (PZQ) treatment: doses at week 8 and 52.
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Intensive praziquantel (PZQ) treatment
Number of subjects: 480

Group type: COMPARATOR
Intervention: Standard praziquantel (PZQ) treatment
Number of subjects: 480
Study: 33243291

Group type: EXPERIMENTAL
Intervention: RAPIDS intervention (fentanyl-specific overdose education, behavior change motivational interviewing sessions, fentanyl test strip training, and distribution of fentanyl test strips for personal use)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard overdose education (control)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: RAPIDS intervention
Number of subjects: 500
Study: 36125447

Group type: EXPERIMENTAL
Intervention: TRM (δ-tocotrienol 250 mg; resveratrol 150 mg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (cellulose 400 mg)
Number of subjects: 82
Study: 33484821

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 34281918

Group type: EXPERIMENTAL
Intervention: Parkinson's Holter monitoring for 7 days
Number of subjects: 162

Group type: COMPARATOR
Intervention: Diary of motor fluctuations for 7 days
Number of subjects: 162

Group type: COMPARATOR
Intervention: Clinical information collected during consultation
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Parkinson's Holter monitoring
Number of subjects: 162
Study: 36068181

Group type: EXPERIMENTAL
Intervention: Behavioural intervention to increase physical activity in daily living (PADL)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 49
Study: 34431871

Group type: EXPERIMENTAL
Intervention: CR with CPAP (10 to 12 cmH2O)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard inpatient CR without CPAP (Control Group - CG)
Number of subjects: 20